Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Stephen A Johnson. (2006) Advances in the treatment of Waldenström’s macroglobulinemia. Expert Review of Anticancer Therapy 6:3, pages 329-334.
Read now
Read now
Roger G Owen. (2001) Treatment options in Waldenström’s macroglobulinaemia: the role of the purine analogues. Expert Opinion on Pharmacotherapy 2:6, pages 945-952.
Read now
Read now
L. T. Nordquist, H. I. Saba & L. C. Moscinski. (2001) IgM Myeloma: An IgM Gammopathy Distinct from Waldenstrom's Macroglobulinemia. Hematology 6:1, pages 53-58.
Read now
Read now
M. A. Dimopoulos, S. O'brien, H. Kantarjian, E. E. Estey, M. J. Keating & R. Alexanian. (1993) Treatment of Waldenstrom's Macroglobulinemia with Nucleoside Analogues. Leukemia & Lymphoma 11:sup2, pages 105-108.
Read now
Read now
Janet Cuttner. (1991) Waldenström's Macroglobulinemia. Cancer Investigation 9:1, pages 107-107.
Read now
Read now
Articles from other publishers (43)
Steven P. Treon, Jorge J. Castillo, Zachary R. Hunter & Giampaolo Merlini. 2018. Hematology. Hematology
1419
1431.e5
.
Steven P. Treon, Giampaolo Merlini & Meletios Dimopoulos. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
617
638
.
Steven P. Treon, Giampaolo Merlini & Meletios A. Dimopoulos. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms
191
220
.
A. Santos-Lozano, A. Morales-Gonzalez, F. Sanchis-Gomar, C. Cristi-Montero, C. Fiuza-Luces, H. Pareja-Galeano, J. Martínez-López, N. Garatachea & A. Lucia. (2016) Response rate to the treatment of Waldenström macroglobulinemia: A meta-analysis of the results of clinical trials. Critical Reviews in Oncology/Hematology 105, pages 118-126.
Crossref
Crossref
Parvathi G, Metta Raja Gopal & Bhagyalakshmi A. (2015) MULTIPLE MYELOMA PRESENTED AS AN ANTERIOR CHEST WALL MASS DIAGNOSED BY CYTOLOGICAL EXAMINATION : A CASE REPORT. Journal of Evidence Based Medicine and Healthcare 2:8, pages 1072-1076.
Crossref
Crossref
Véronique Leblond, Giampaolo Merlini, Steven P. Treon, Scott Rodig & Jan Delabie. 2014. Rare Lymphomas. Rare Lymphomas
303
329
.
Steven P. Treon & Giampaolo Merlini. 2013. Myeloma. Myeloma
190
215
.
Steven P. Treon & Giampaolo Merlini. 2013. Lymphoma. Lymphoma
83
109
.
Steven P. Treon & Giampaolo Merlini. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies
207
227
.
Stephen M. Ansell, Robert A. Kyle, Craig B. Reeder, Rafael Fonseca, Joseph R. Mikhael, William G. Morice, P. Leif Bergsagel, Francis K. Buadi, Joseph P. Colgan, David Dingli, Angela Dispenzieri, Philip R. Greipp, Thomas M. Habermann, Suzanne R. Hayman, David J. Inwards, Patrick B. Johnston, Shaji K. Kumar, Martha Q. Lacy, John A. Lust, Svetomir N. Markovic, Ivana N.M. Micallef, Grzegorz S. Nowakowski, Luis F. Porrata, Vivek Roy, Stephen J. Russell, Kristen E. Detweiler Short, A. Keith Stewart, Carrie A. Thompson, Thomas E. Witzig, Steven R. Zeldenrust, Robert J. Dalton, S. Vincent Rajkumar & Morie A. Gertz. (2010) Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines. Mayo Clinic Proceedings 85:9, pages 824-833.
Crossref
Crossref
Kun Yang, Jianlong Tan & Taixiang Wu. (2009) Alkylating agents for Waldenstrom's macroglobulinaemia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Steven P. Treon & Giampaolo Merlini. 2009. Treatment of Multiple Myeloma and Related Disorders. Treatment of Multiple Myeloma and Related Disorders
129
149
.
Arun Vijay & Morie A. Gertz. (2008) Current Treatment Options for Waldenström Macroglobulinemia. Clinical Lymphoma and Myeloma 8:4, pages 219-229.
Crossref
Crossref
K Yang, JL Tan & TX Wu. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Arun VijayMorie A. Gertz. (2007) Waldenström macroglobulinemia. Blood 109:12, pages 5096-5103.
Crossref
Crossref
Christine I. Chen, C. Tom Kouroukis, Darrell White, Michael Voralia, Edward Stadtmauer, A. Keith Stewart, John J. Wright, Jean Powers, Wendy Walsh & Elizabeth Eisenhauer. (2007) Bortezomib Is Active in Patients With Untreated or Relapsed Waldenström's Macroglobulinemia: A Phase II Study of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology 25:12, pages 1570-1575.
Crossref
Crossref
S. A. Johnson, J. Birchall, C. Luckie, D. G. Oscier & R. G. Owen. (2006) Guidelines on the management of Waldenstrom macroglobulinaemia*. British Journal of Haematology 132:6, pages 683-697.
Crossref
Crossref
Magnus Björkholm. 2006. The Lymphomas. The Lymphomas
374
380
.
Manfred Hensel, Matthias Villalobos, Martin Kornacker, Fatime Krasniqi & Anthony D. Ho. (2005) Pentostatin/Cyclophosphamide with or Without Rituximab: An Effective Regimen for Patients with Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma. Clinical Lymphoma and Myeloma 6:2, pages 131-135.
Crossref
Crossref
Morie A. Gertz. (2005) Waldenström macroglobulinemia: A review of therapy. American Journal of Hematology 79:2, pages 147-157.
Crossref
Crossref
Stephen A. Johnson, Roger G. Owen, David G. Oscier, Veronique Leblond, Vincent Levy, Ulrich Jaeger & John F. Seymour. (2005) Phase III Study of Chlorambucil Versus Fludarabine as Initial Therapy for Waldenstr?m's Macroglobulinemia and Related Disorders. Clinical Lymphoma 5:4, pages 294-297.
Crossref
Crossref
Ombretta Annibali, Maria Teresa Petrucci, Vincenza Martini, Maria Cristina Tirindelli, Anna Levi, Carolina Fossati, Patrizia Del Bianco, Franco Mandelli, Robin Foa & Giuseppe Avvisati. (2005) Treatment of 72 newly diagnosed Waldenström macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone. Cancer 103:3, pages 582-587.
Crossref
Crossref
Magnus Björkholm. (2004) Treatment Options in Waldenstrom's Macroglobulinemia. Clinical Lymphoma 5:3, pages 155-162.
Crossref
Crossref
Irene M. Ghobrial & Thomas E. Witzig. (2004) Waldenström macroglobulinemia. Current Treatment Options in Oncology 5:3, pages 239-247.
Crossref
Crossref
Giampaolo Merlini & Steven Treon. 2004. Multiple Myeloma and Related Disorders. Multiple Myeloma and Related Disorders
429
451
.
C.I. Chen. (2004) Treatment for Waldenstrom’s macroglobulinemia. Annals of Oncology 15:4, pages 550-558.
Crossref
Crossref
Jerry M. Winkler & Rafael Fonseca. 2004. Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders. Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
205
225
.
Irene M Ghobrial, Morie A Gertz & Rafael Fonseca. (2003) Waldenström macroglobulinaemia. The Lancet Oncology 4:11, pages 679-685.
Crossref
Crossref
Donna M. Weber, Meletios A. Dimopoulos, Kay Delasalle, Kim Rankin, Maria Gavino & Raymond Alexanian. (2003) 2-chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia. Seminars in Oncology 30:2, pages 243-247.
Crossref
Crossref
Morie A. Gertz, Athanasios Anagnostopoulos, Kenneth Anderson, Andrew R. Branagan, Morton Coleman, Stanley R. Frankel, Sergio Giralt, Todd Levine, Nikhil Munshi, Alan Pestronk, Vincent Rajkumar & Steven P. Treon. (2003) Treatment recommendations in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Seminars in Oncology 30:2, pages 121-126.
Crossref
Crossref
S.A Johnson, D.G Oscier & V Leblond. (2002) Waldenstr?m's macroglobulinaemia. Blood Reviews 16:3, pages 175-184.
Crossref
Crossref
Ramón García-Sanz, Silvia Montoto, Agustín Torrequebrada, Alfonso García De Coca, José Petit, Anna Sureda, José Antonio Rodríguez-García, Pilar Massó, Ana Pérez-Aliaga, María Dolores Monteagudo, Isabel Navarro, Gemma Moreno, Carmen Toledo, Aránzazu Alonso, Carles Besses, Joan Besalduch, Isidro Jarque, Perla Salama, José Angel Hernández Rivas, Blanca Navarro, Joan Bladé & Jesús F. San Miguel. (2001) Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases. British Journal of Haematology 115:3, pages 575-582.
Crossref
Crossref
Véronique Leblond, Vincent Lévy, Frédéric Maloisel, Bruno Cazin, Jean-Paul Fermand, Jean-Luc Harousseau, Liliane Remenieras, Raphaël Porcher, Martine Gardembas, Gérald Marit, Eric Deconinck, Bernard Desablens, François Guilhot, Guilaine Philippe, Aspasia Stamatoullas & Odile Guibon. (2001) Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease. Blood 98:9, pages 2640-2644.
Crossref
Crossref
V Lévy, R Porcher, V Leblond, JP Fermand, B Cazin, F Maloisel, JL Harousseau, L Remenieras, O Guibon & S Chevret. (2001) Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis. Leukemia 15:9, pages 1466-1470.
Crossref
Crossref
Madhav V. DhodapkarJoth L. JacobsonMorie A. GertzSaul E. RivkinG. David RoodmanJoseph M. TuscanoMuhammad ShurafaRobert A. KyleJohn J. CrowleyBart Barlogie. (2001) Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). Blood 98:1, pages 41-48.
Crossref
Crossref
R. G. Owen, S. A. Johnson & G. J. Morgan. (2000) Waldenstr�m's macroglobulinaemia: Laboratory diagnosis and treatment. Hematological Oncology 18:2, pages 41-49.
Crossref
Crossref
K. Raman Desikan, Madhav V. Dhodapkar & Bart Barlogie. (2000) Waldenström’s macroglobulinemia. Current Treatment Options in Oncology 1:2, pages 97-103.
Crossref
Crossref
Robert A. Kyle, Philip R. Greipp, Morie A. Gertz, Thomas E. Witzig, John A. Lust, Martha Q. Lacy & Terry M. Therneau. (2001) Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil. British Journal of Haematology 108:4, pages 737-742.
Crossref
Crossref
Morie A. Gertz, Rafael Fonseca & S. Vincent Rajkumar. (2000) Waldenström's Macroglobulinemia. The Oncologist 5:1, pages 63-67.
Crossref
Crossref
R. Desikan, M. Dhodapkar,D. Siegel, A. Fassas, J. Singh, S. Singhal, J. Mehta, D. Vesole, G. Tricot, S. Jagannath, E. Anaissie, B. Barlogie & N. C. Munshi. (2005) High‐dose therapy with autologous haemopoietic stem cell support for Waldenström's macroglobulinaemia. British Journal of Haematology 105:4, pages 993-996.
Crossref
Crossref
Morie A. GertzRobert A. Kyle. (1995) Hyperviscosity Syndrome. Journal of Intensive Care Medicine 10:3, pages 128-141.
Crossref
Crossref
P. L. Zinzani, F. Gherlinzoni, M. Bendandi, A. Zaccaria, E. Aitini, M. Salvucci & S. Tura. (2009) Fludarabine treatment in resistant Waldenstrom's macroglobulinemia. European Journal of Haematology 54:2, pages 120-123.
Crossref
Crossref
Meletios A. Dimopoulos, Susan O'Brien, Hagop Kantarjian, Sherry Pierce, Kay Delasalle, Bart Barlogie, Raymond Alexanian & Michael J. Keating. (1993) Fludarabine therapy in Waldenstr?m's macroglobulinemia. The American Journal of Medicine 95:1, pages 49-52.
Crossref
Crossref